If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetro Matad Regulatory News (MATD)

Share Price Information for Petro Matad (MATD)

Share Price is delayed by 15 minutes
Get Live Data
1.10    0.00 (0.00%)
Bid:
1.05
Ask:
1.15
Spread: 0.10 (9.524%)
Market Cap: £20.45m
MATD Live PriceLast checked at - London Stock Exchange

Intraday Petro Matad Share Chart

Progressive publishes new research

19 Jan 2022 07:18

RNS Number : 9384Y
Petro Matad Limited
19 January 2022
 

Promising outlook for 2022 - Heron moving ahead

 

Petro Matad issued a trading update in December highlighting that the company is on track for its target of starting production at its Heron oil discovery in Mongolia in the middle of 2022. The Heron field is located in Block XX, where the company has a 100% working interest. This production will allow Petro Matad to start generating cash flow, which will give the company the funds required to accelerate its anticipated work programme.

 

 

Click here for full analysis

 

Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

 

Progressive is an equity research and investor engagement company. FCA authorised and regulated, the firm has a 15-strong team of highly experienced analysts. We provide Institutional grade research and connect companies with investors across every sector of the market.

 

www.progressive-research.com

 

Broad coverage

 

Analyst calibre

 

across 12 sectors

 

 

 

 

 

 

Business Services

Oil & Gas

15analysts

with average

20years

Financials

Property

experience of

Healthcare

Retail

Industrials

Technology

30+

techMARK

Investment Trusts

Telecoms

industry based

Extel

Mining

Utilities

awards

StarMine

 

For further information please contact:

 

Keith Hodgskiss

+44 (0) 20 7781 5300

khodgskiss@progressive-research.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAXFNFFKAEEA
Date   Source Headline
10th Dec 20207:00 amRNSCompany AGM Dial-In & Registration Details
7th Dec 20204:41 pmRNSSecond Price Monitoring Extn
7th Dec 20204:36 pmRNSPrice Monitoring Extension
7th Dec 20202:05 pmRNSSecond Price Monitoring Extn
7th Dec 20202:00 pmRNSPrice Monitoring Extension
4th Dec 20207:00 amRNSUpdate on Company AGM and Exploitation Licence
17th Nov 20207:00 amRNSNotice of AGM
8th Oct 20207:00 amRNSOperational Update and Planned Retirement of CFO
19th Aug 20207:00 amRNSConditional Share Awards and Total Voting Rights
17th Aug 20207:00 amRNSInterim results
15th Jul 20204:35 pmRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSExercise of Share Awards and Voting Rights
16th Jun 202012:00 pmRNSExercise of Conditional Share and Voting Rights
15th Jun 20207:00 amRNSFinal Results
4th Jun 20204:41 pmRNSSecond Price Monitoring Extn
4th Jun 20204:36 pmRNSPrice Monitoring Extension
4th Jun 20202:05 pmRNSSecond Price Monitoring Extn
4th Jun 20202:00 pmRNSPrice Monitoring Extension
4th Jun 202011:00 amRNSPrice Monitoring Extension
2nd Jun 20202:06 pmRNSSecond Price Monitoring Extn
2nd Jun 20202:00 pmRNSPrice Monitoring Extension
11th May 20207:00 amRNSCost Optimisation and Exploitation License Update
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
7th Apr 20202:05 pmRNSSecond Price Monitoring Extn
7th Apr 20202:00 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSOperational Update
26th Feb 20207:04 amRNSSecond Price Monitoring Extn
26th Feb 20207:02 amRNSPrice Monitoring Extension
25th Feb 20204:41 pmRNSSecond Price Monitoring Extn
25th Feb 20204:35 pmRNSPrice Monitoring Extension
7th Feb 20207:00 amRNSTotal Voting Rights
31st Dec 20197:00 amRNSDirector/PDMR Shareholding
30th Dec 20197:00 amRNSConditional Share Awards and Total Voting Rights
23rd Dec 20197:00 amRNSAward of Conditional Share Awards
19th Nov 201910:02 amRNSResult of AGM
11th Nov 20197:00 amRNSCorporate Presentation and Shareholder Meeting
5th Nov 201910:00 amRNSShareholder Update Meeting and Presentation
24th Oct 20194:40 pmRNSSecond Price Monitoring Extn
24th Oct 20194:35 pmRNSPrice Monitoring Extension
24th Oct 20197:00 amRNSResults of testing at Heron-1
21st Oct 201912:36 pmRNSNotice of AGM - Correction
21st Oct 20197:00 amRNSNotice of AGM
17th Oct 201911:05 amRNSSecond Price Monitoring Extn
17th Oct 201911:00 amRNSPrice Monitoring Extension
17th Oct 20197:00 amRNSGazelle-1 Results and Operational Update
3rd Oct 20197:00 amRNSCommencement of Testing of Heron-1
19th Sep 20197:00 amRNSSpud of exploration well Gazelle-1
17th Sep 20192:05 pmRNSSecond Price Monitoring Extn
17th Sep 20192:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.